Gene

Search results

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	Disease ID
1	Adrenergic signaling in cardiomyocytes 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
2	Adrenergic signaling in cardiomyocytes 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
3	Adrenergic signaling in cardiomyocytes 💬	[2] ADRB1, ADRB2 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
4	Adrenergic signaling in cardiomyocytes 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
5	Adrenergic signaling in cardiomyocytes 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
6	Adrenergic signaling in cardiomyocytes 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
7	AGE-RAGE signaling pathway in diabetic complications 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
8	AGE-RAGE signaling pathway in diabetic complications 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
9	Aldosterone synthesis and secretion 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
10	Aldosterone synthesis and secretion 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
11	Aldosterone synthesis and secretion 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
12	Alzheimer disease 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
13	Amphetamine addiction 💬	[2] CACNA1C, CACNA1D 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
14	Apelin signaling pathway 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
15	Apelin signaling pathway 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
16	Arrhythmogenic right ventricular cardiomyopathy 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
17	Calcium signaling pathway 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
18	Calcium signaling pathway 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
19	Calcium signaling pathway 💬	[3] ADRB1, ADRB2, ADRB3 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
20	Calcium signaling pathway 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
21	Calcium signaling pathway 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
22	Calcium signaling pathway 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
23	cAMP signaling pathway 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
24	cAMP signaling pathway 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
25	cAMP signaling pathway 💬	[2] ADRB1, ADRB2 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
26	cAMP signaling pathway 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
27	Carbohydrate digestion and absorption 💬	[1] CACNA1D 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
28	Cardiac muscle contraction 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
29	Cellular senescence 💬	[1] CACNA1D 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
30	cGMP-PKG signaling pathway 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
31	cGMP-PKG signaling pathway 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
32	cGMP-PKG signaling pathway 💬	[3] ADRB1, ADRB2, ADRB3 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
33	cGMP-PKG signaling pathway 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
34	cGMP-PKG signaling pathway 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
35	cGMP-PKG signaling pathway 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
36	Chagas disease 💬	[1] ACE 💬	D03753 💬	Perindopril	[4] 58, 113, 167, 222 💬
37	Chemical carcinogenesis - receptor activation 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
38	Chemical carcinogenesis - receptor activation 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
39	Chemical carcinogenesis - receptor activation 💬	[3] ADRB1, ADRB2, ADRB3 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
40	Chemical carcinogenesis - receptor activation 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
41	Cholinergic synapse 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
42	Circadian entrainment 💬	[2] CACNA1C, CACNA1D 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
43	Coronavirus disease - COVID-19 💬	[1] ACE 💬	D03753 💬	Perindopril	[4] 58, 113, 167, 222 💬
44	Coronavirus disease - COVID-19 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
45	Coronavirus disease - COVID-19 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
46	Cortisol synthesis and secretion 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
47	Cortisol synthesis and secretion 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
48	Cortisol synthesis and secretion 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
49	Cushing syndrome 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
50	Cushing syndrome 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
51	Cushing syndrome 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
52	Diabetic cardiomyopathy 💬	[1] ACE 💬	D03753 💬	Perindopril	[4] 58, 113, 167, 222 💬
53	Diabetic cardiomyopathy 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
54	Diabetic cardiomyopathy 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
55	Diabetic cardiomyopathy 💬	[1] REN 💬	D03208 💬	Aliskiren	[3] 66, 167, 222 💬
56	Dilated cardiomyopathy 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
57	Dilated cardiomyopathy 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
58	Dilated cardiomyopathy 💬	[1] ADRB1 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
59	Dilated cardiomyopathy 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
60	Dopaminergic synapse 💬	[2] CACNA1C, CACNA1D 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
61	GABAergic synapse 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
62	Gap junction 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
63	Gap junction 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
64	Gap junction 💬	[1] ADRB1 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
65	Glutamatergic synapse 💬	[2] CACNA1C, CACNA1D 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
66	GnRH secretion 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
67	GnRH signaling pathway 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
68	Growth hormone synthesis, secretion and action 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
69	Hypertrophic cardiomyopathy 💬	[1] ACE 💬	D03753 💬	Perindopril	[4] 58, 113, 167, 222 💬
70	Hypertrophic cardiomyopathy 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
71	Insulin secretion 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
72	Long-term potentiation 💬	[1] CACNA1C 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
73	MAPK signaling pathway 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
74	Neuroactive ligand-receptor interaction 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
75	Neuroactive ligand-receptor interaction 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
76	Neuroactive ligand-receptor interaction 💬	[3] ADRB1, ADRB2, ADRB3 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
77	Neuroactive ligand-receptor interaction 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
78	Neuroactive ligand-receptor interaction 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
79	Oxytocin signaling pathway 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
80	Pathways in cancer 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
81	Pathways in cancer 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
82	Pathways of neurodegeneration - multiple diseases 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
83	Phospholipase D signaling pathway 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
84	Phospholipase D signaling pathway 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
85	Prion disease 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
86	Regulation of lipolysis in adipocytes 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
87	Regulation of lipolysis in adipocytes 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
88	Regulation of lipolysis in adipocytes 💬	[3] ADRB1, ADRB2, ADRB3 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
89	Renin secretion 💬	[1] ACE 💬	D03753 💬	Perindopril	[4] 58, 113, 167, 222 💬
90	Renin secretion 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
91	Renin secretion 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
92	Renin secretion 💬	[3] ADRB1, ADRB2, ADRB3 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
93	Renin secretion 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
94	Renin secretion 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
95	Renin secretion 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
96	Renin secretion 💬	[1] REN 💬	D03208 💬	Aliskiren	[3] 66, 167, 222 💬
97	Renin-angiotensin system 💬	[1] ACE 💬	D03753 💬	Perindopril	[4] 58, 113, 167, 222 💬
98	Renin-angiotensin system 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
99	Renin-angiotensin system 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
100	Renin-angiotensin system 💬	[1] REN 💬	D03208 💬	Aliskiren	[3] 66, 167, 222 💬
101	Retrograde endocannabinoid signaling 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
102	Salivary secretion 💬	[1] ADRB1 💬	D00235 💬	Atenolol	[1] 167 💬
103	Salivary secretion 💬	[1] ADRB1 💬	D05127 💬	Nebivolol	[4] 17, 85, 113, 167 💬
104	Salivary secretion 💬	[3] ADRB1, ADRB2, ADRB3 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
105	Serotonergic synapse 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
106	Taste transduction 💬	[1] CACNA1C 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
107	Thermogenesis 💬	[1] ADRB3 💬	D08443 💬	Propranolol	[6] 6 , 158, 167, 227, 278, 296 💬
108	Tight junction 💬	[1] CACNA1D 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
109	Type II diabetes mellitus 💬	[2] CACNA1C, CACNA1D 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬
110	Vascular smooth muscle contraction 💬	[1] AGTR1 💬	D00523 💬	Irbesartan	[4] 66, 167, 168, 222 💬
111	Vascular smooth muscle contraction 💬	[1] AGTR1 💬	D08146 💬	Losartan	[17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
112	Vascular smooth muscle contraction 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D02356 💬	Verapamil	[4] 58, 96, 140, 167 💬